News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,501 Results
Type
Article (10730)
Company Profile (29)
Press Release (55742)
Section
Business (16487)
Career Advice (1630)
Deals (2799)
Drug Delivery (46)
Drug Development (8280)
Employer Resources (109)
FDA (1699)
Job Trends (2120)
News (31143)
Policy (4533)
Tag
Academia (673)
Alliances (4328)
Alzheimer's disease (199)
Antibody-drug conjugate (ADC) (27)
Approvals (1674)
Artificial intelligence (42)
Bankruptcy (45)
Best Places to Work (1612)
Biotechnology (22)
Breast cancer (21)
Cancer (219)
Career advice (1327)
Career pathing (25)
CAR-T (27)
Cell therapy (73)
Clinical research (6073)
Collaboration (86)
COVID-19 (733)
C-suite (26)
Data (181)
Diabetes (41)
Diagnostics (635)
Diversity, equity & inclusion (29)
Drug pricing (45)
Earnings (4580)
Editorial (27)
Employer resources (98)
Events (7674)
Executive appointments (63)
FDA (1805)
Funding (95)
Gene editing (22)
Gene therapy (61)
GLP-1 (180)
Government (922)
Healthcare (2619)
Infectious disease (753)
Interviews (318)
IPO (1061)
Job creations (562)
Job search strategy (1104)
Layoffs (101)
Legal (1617)
Lung cancer (30)
Management (40)
Manufacturing (45)
Medical device (1235)
Medtech (1236)
Mergers & acquisitions (1752)
Metabolic disorders (132)
Neuroscience (280)
NextGen: Class of 2025 (1239)
Non-profit (945)
Northern California (214)
Obesity (84)
Opinion (174)
Patents (25)
People (5268)
Phase I (2042)
Phase II (2639)
Phase III (2210)
Pipeline (100)
Policy (46)
Postmarket research (250)
Preclinical (789)
Rare diseases (72)
Real estate (784)
Recruiting (44)
Regulatory (2330)
Research institute (517)
Resumes & cover letters (287)
Series A (21)
Southern California (211)
Startups (528)
United States (1849)
Vaccines (179)
Weight loss (81)
Date
Today (18)
Last 7 days (94)
Last 30 days (322)
Last 365 days (3754)
2025 (662)
2024 (3720)
2023 (3862)
2022 (4866)
2021 (5707)
2020 (5675)
2019 (6141)
2018 (4817)
2017 (3586)
2016 (3793)
2015 (4185)
2014 (2789)
2013 (2154)
2012 (2397)
2011 (2456)
2010 (1672)
Location
Africa (320)
Asia (3600)
Australia (860)
California (575)
Canada (152)
China (40)
Connecticut (24)
Europe (8630)
Florida (52)
Illinois (44)
Indiana (24)
Maryland (118)
Massachusetts (322)
Minnesota (21)
New Jersey (108)
New York (158)
North Carolina (65)
Northern California (214)
Pennsylvania (95)
South America (344)
Southern California (211)
Texas (82)
Washington State (33)
66,501 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
How To Mine Biopharma’s IP Storeroom for Rare Disease Drugs, Just Like SpringWorks
SpringWorks Therapeutics is the perfect case study for rescuing a discontinued assets. It’s time to repeat the process for every rare disease, experts say.
February 26, 2025
·
5 min read
·
Annalee Armstrong
Policy
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., was selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution for the DOD’s Manufacturing Optimization Program.
June 25, 2024
·
7 min read
Business
Deep Dive: JPM M&A Rush Just the Start, as Biopharma Insider Predicts Mega-Deals to Come
The J.P. Morgan Healthcare Conference started off with a flurry of deals that reinvigorated excitement across the biopharma industry. Johnson & Johnson moved to acquire Intra-Cellular Therapies for $14.6 billion, breaking a dealmaking barrier that kept Big Pharma’s 2024 biotech buyouts to under $5 billion.
January 29, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
February 19, 2025
·
6 min read
BioForest
Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC
Gilead Sciences, Inc. announced the company has been named one of America’s Most JUST Companies.
February 9, 2024
·
3 min read
Biotech Bay
Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
Bristol Myers Squibb is honored to announce it has been recognized as One of America’s Most JUST Companies.
February 5, 2024
·
3 min read
Press Releases
Elegen Now Ships Plasmids Up to 15 kb in Just 10 Business Days, Bringing Unprecedented Speed to Long DNA Synthesis
January 9, 2025
·
2 min read
Press Releases
Bolt Biotherapeutics to Participate in Upcoming March 2025 Conferences
February 26, 2025
·
1 min read
Mergers & Acquisitions
Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
By far, the largest acquisition of 2024 was Novo Holdings’ yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion. Outside of that, the leading pharmaceutical companies kept to less than $5 billion per deal.
December 11, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
February 21, 2025
·
3 min read
1 of 6,651
Next
